CoChat

Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypes

Open access
Lizotte, Patrick H., Ivanova, Elena V., Awad, Mark M., Jones, Robert E., Keogh, Lauren, Liu, Hongye, Dries, Ruben, Almonte, Christina, Herter-Sprie, Grit S., Santos, Abigail, Feeney, Nora B., Paweletz, Cloud P., Kulkarni, Meghana M., Bass, Adam J., Rustgi, Anil K., Yuan, Guo-Cheng, Kufe, Donald W., Jänne, Pasi A., Hammerman, Peter S., Sholl, Lynette M., Hodi, F. Stephen, Richards, William G., Bueno, Raphael, English, Jessie M., Bittinger, Mark A., Wong, Kwok-Kin · 2016 · JCI Insight
Cited by 124

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

BACKGROUND. Immune checkpoint blockade improves survival in a subset of patients with non–small-cell lung cancer (NSCLC), but robust biomarkers that predict response to PD-1 pathway inhibitors are lacking. Furthermore, our understanding of the diversity of the NSCLC tumor immune microenvironment remains limited. METHODS. We performed comprehensive flow cytometric immunoprofiling on both tumor and immune cells from 51 NSCLCs and integrated this analysis with clinical and histopathologic characteristics, next-generation sequencing, mRNA expression, and PD-L1 immunohistochemistry (IHC). RESULTS. Cytometric profiling identified an immunologically “hot” cluster with abundant CD8 + T cells expressing high levels of PD-1 and TIM-3 and an immunologically “cold” cluster with lower relative abundance of CD8 + T cells and expression of inhibitory markers. The “hot” cluster was highly enriched for expression of genes associated with T cell trafficking and cytotoxic function and high PD-L1 expression by IHC. There was no correlation between immunophenotype and KRAS or EGFR mutation, or patient smoking history, but we did observe an enrichment of squamous subtype and tumors with higher mutation burden in the “hot” cluster. Additionally, approximately 20% of cases had high B cell infiltrates with a subset producing IL-10. CONCLUSIONS. Our results support the use of immune-based metrics to study response and resistance to immunotherapy in lung cancer. FUNDING. The Robert A. and Renée E. Belfer Family Foundation, Expect Miracles Foundation, Starr Cancer Consortium, Stand Up to Cancer Foundation, Conquer Cancer Foundation, International Association for the Study of Lung Cancer, National Cancer Institute (R01 CA205150), and the Damon Runyon Cancer Research Foundation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci.insight.89014

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 124

Metadata

Authors
Lizotte, P. H., Ivanova, E. V., Awad, M. M., Jones, R. E., Keogh, L., Liu, H., Dries, R., Almonte, C., Herter-Sprie, G. S., Santos, A., Feeney, N. B., Paweletz, C. P., Kulkarni, M. M., Bass, A. J., Rustgi, A. K., Yuan, G.-C., Kufe, D. W., Jänne, P. A., Hammerman, P. S., Sholl, L. M., Hodi, F. S., Richards, W. G., Bueno, R., English, J. M., Bittinger, M. A., & Wong, K.-K.
Venue
JCI Insight
Published
2016-09-08
Volume
1
Issue
14
Pages
e89014-e89014
ISSN
2379-3708 (ISSN-L)
OpenAlex
W2518412322
Cited by
124
References
17
FWCI
8.19
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypes. https://app.cochat.ai/papers/10.1172/jci.insight.89014
The paper
Lizotte, P. H., Ivanova, E. V., Awad, M. M., Jones, R. E., Keogh, L., Liu, H., Dries, R., Almonte, C., Herter-Sprie, G. S., Santos, A., Feeney, N. B., Paweletz, C. P., Kulkarni, M. M., Bass, A. J., Rustgi, A. K., Yuan, G.-C., Kufe, D. W., Jänne, P. A., Hammerman, P. S., . . . Wong, K.-K. (2016). Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypes. JCI Insight. https://doi.org/10.1172/jci.insight.89014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.